Table 6.
Morbidity and Mortality of the study population.
| Variable | HMF Group (n = 96) n (%) |
BMF Group (n = 96) n (%) |
p-Value |
|---|---|---|---|
| Mortality | 5 (5%) | 3 (3%) | n.s. |
| IVH | 26 (27%) | 23 (24%) | n.s. |
| - I and II | 13 (14%) | 15 (16%) | |
| - III and IV | 13 (14%) | 8 (8%) | |
| PVL | 3 (4%) | 1 (1%) | n.s. |
| Sepsis | 45 (47%) | 41 (43%) | n.s. |
| PDA | 58 (60%) | 56 (58%) | n.s. |
| - Ligature | 4 (4%) | 5 (5%) | |
| BPD | 29 (30%) | 23 (23%) | n.s. |
| ROP | 53 (55%) | 45 (47%) | n.s. |
| - I-III | 53 (55%) | 43 (45%) | |
| - III+ | 0 (0%) | 2 (2%) | |
| NEC | 10 (10%) | 8 (8%) | n.s. |
| - Abdominal surgery | 7 (7%) | 7 (7%) | n.s. |
| FIP | 5 (5%) | 5 (5%) | n.s. |
IVH = intraventricular hemorrhage, PVL = periventricular leukomalacia, PDA = patent ductus arteriosus, BPD = bronchopulmonary dysplasia, ROP = retinopathy of prematurity, NEC = necrotizing enterocolitis, FIP = focal intestinal perforation, HM = human milk, HMF = human milk based fortifier, BMF = bovine based human milk fortifier; Chi-Squared test (or Fishers Exact test) as appropriate.